Gerhard Zugmaier

Gerhard Zugmaier

UNVERIFIED PROFILE

Are you Gerhard Zugmaier?   Register this Author

Register author
Gerhard Zugmaier

Gerhard Zugmaier

Publications by authors named "Gerhard Zugmaier"

Are you Gerhard Zugmaier?   Register this Author

39Publications

1605Reads

46Profile Views

[Antibodies in hematology by the example of acute lymphatic leukemia].

Authors:
Gerhard Zugmaier

Internist (Berl) 2019 Oct;60(10):1032-1035

AMGEN Research (Munich) GmbH, Staffelseestraße 2, 81477, München, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00108-019-00668-0DOI Listing
October 2019

Aneuploidy in childhood B cell acute lymphoblastic leukaemia - also a relevant prognostic factor in relapsed disease?

Authors:
Gerhard Zugmaier

Br J Haematol 2019 Mar 5;184(6):895-896. Epub 2019 Feb 5.

Department of Haematology, Oncology and Immunology, Pilipps University Marburg, Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15769DOI Listing
March 2019

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

J Clin Oncol 2016 12 31;34(36):4381-4389. Epub 2016 Oct 31.

Arend von Stackelberg, Charité Campus Virchow, Berlin; Gerhard Zugmaier, Amgen Research (Munich), Munich; Rupert Handgretinger, University of Tübingen, Tübingen; Peter Bader, Hospital for Children and Adolescents III, University of Frankfurt, Frankfurt; Paul Gerhardt Schlegel, University Children's Hospital Würzburg, Würzburg; Arndt Borkhardt, University of Düsseldorf Medical Faculty, Düsseldorf, Germany; Franco Locatelli, Ospedale Pediatrico Bambino Gesù, Rome, University of Pavia, Pavia; Carmelo Rizzari, San Gerardo Hospital, University of Milano-Bicocca, Monza; Chiara Messina, Clinica di Oncoematologia Pediatrica, Università degli Studi di Padova, Padova, Italy; Benoît Brethon, Hôpital Robert Debré, Service Hématologie-Immunologie Pédiatrique, Paris; Gérard Michel, Hôpital de la Timone, Marseille, France; Christian M. Zwaan, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, Netherlands; Tanya M. Trippett, Memorial Sloan Kettering Cancer Center, New York, NY; Maureen M. O'Brien, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Deepa Bhojwani, Children's Hospital of Los Angeles; Kuolung Hu and Min Zhu, Amgen, Thousand Oaks, CA; Susan R. Rheingold, Children's Hospital of Philadelphia, Philadelphia, PA; Todd Michael Cooper, Seattle Children's Hospital, Seattle, WA; Phillip Barnette, Primary Children's Medical Center, Salt Lake City, UT; Steven G. DuBois, Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, MA; Lia Gore, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO; and James A. Whitlock, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.67.3301
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.67.3301DOI Listing
December 2016

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study.

J Clin Oncol 2016 Apr 16;34(10):1104-11. Epub 2016 Feb 16.

Maria-Elisabeth Goebeler, Stefan Knop, Max S. Topp, Hermann Einsele, and Ralf C. Bargou, Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg; Andreas Viardot, University Ulm; Peter Kufer, Gerhard Zugmaier, Matthias Klinger, Andreas Wolf, Margit Schmidt, and Patrick A. Baeuerle, Amgen Research (Munich); Brigitte Dorsch, Metronomia Clinical Research, Munich; Richard Noppeney, University of Essen Medical Center, Essen; Georg Hess, Johannes Gutenberg-University, Mainz; Stefan Kallert and Andreas Mackensen, University of Erlangen Medical Center, Erlangen; Kathrin Rupertus and Lothar Kanz, University of Tübingen Medical Center, Tübingen; Martin Libicher, Diakoniekrankenhaus Schwäbisch-Hall, Schwäbisch-Hall; Jürgen Scheele, University of Freiburg Medical Center; Eugen Leo, LEOConsulting, Freiburg, Germany; and Dirk Nagorsen and Beate D. Quednau, Amgen, Thousand Oaks, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.1586DOI Listing
April 2016

Clinical overview of anti-CD19 BiTE(®) and ex vivo data from anti-CD33 BiTE(®) as examples for retargeting T cells in hematologic malignancies.

Mol Immunol 2015 Oct 13;67(2 Pt A):58-66. Epub 2015 Apr 13.

Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany; Clinical Cooperation Group Immunotherapy, Helmholtz Institute Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2015.02.033DOI Listing
October 2015

Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia.

J Clin Oncol 2014 Dec 10;32(36):4134-40. Epub 2014 Nov 10.

Max S. Topp, Hermann Einsele, and Ralf C. Bargou, Universitätsklinikum Würzburg, Würzburg; Nicola Gökbuget, Goethe University; Dieter Hoelzer, Onkologikum, Frankfurt; Gerhard Zugmaier, Petra Klappers, and Noemi Mergen, Amgen Research; Dorothea Wessiepe, Metronomia, Munich; Matthias Stelljes, University of Münster, Münster; Svenja Neumann, Heinz-August Horst, and Monika Brüggemann, University Schleswig Holstein, City Hospital, Kiel; Andreas Viardot, University of Ulm, Ulm; Reinhard Marks, Universitätsklinikum Freiburg, Freiburg; Helmut Diedrich, Medizinische Hochschule Hannover, Hannover; Christoph Faul, Universitätsklinikum Tübingen, Tübingen; Albrecht Reichle, Universitätsklinikum Regensburg, Regensburg, Germany; and Chris Holland and Shilpa Alekar, Amgen, Rockville, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.3247DOI Listing
December 2014

A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.

Cancer Res 2006 Aug;66(15):7554-61

Department of Clinical Chemistry, Robert-Bosch-Hospital, Auerbachstrasse 110, 70376 Stuttgart, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-0634DOI Listing
August 2006

Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells.

Naunyn Schmiedebergs Arch Pharmacol 2005 Feb 8;371(2):141-51. Epub 2005 Feb 8.

Department of Pharmacology and Toxicology, Philipps-University Marburg, School of Medicine, Karl-von-Frisch-Strasse 1, 35033 Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00210-004-1016-4DOI Listing
February 2005

Color Doppler sonographic signs of respiration-dependent hepatofugal portal flow.

J Clin Ultrasound 2004 Feb;32(2):62-8

Department of Internal Medicine, Philipps University, Baldingerstrasse, 35043 Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcu.10226DOI Listing
February 2004

Focal splenic lesions in myeloproliferative disease: association with fatal outcome.

Ann Hematol 2004 Jan 3;83(1):14-7. Epub 2003 Oct 3.

Department of Internal Medicine, Philipps University, Baldingerstrasse, 35043 Marburg/Lahn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-003-0753-7DOI Listing
January 2004

Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients.

Clin Cancer Res 2004 Jan;10(2):491-8

Robert Bosch Hospital, Department of Clinical Chemistry, Stuttgart, Germany.

View Article

Download full-text PDF

Source
January 2004

Color Doppler sonographic mapping of pulmonary lesions: evidence of dual arterial supply by spectral analysis.

J Ultrasound Med 2003 Oct;22(10):1033-9

Medizinische Universitätsklinik, Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7863/jum.2003.22.10.1033DOI Listing
October 2003

Significance of heparin-binding growth factor expression on cells of solid pediatric tumors.

J Pediatr Surg 2003 Sep;38(9):1296-304

Department of Pediatric Surgery, University Tübingen, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-3468(03)00385-3DOI Listing
September 2003

Spontaneous nontraumatic intrasplenic pseudoaneurysm: causes, sonographic diagnosis, and prognosis.

J Clin Ultrasound 2003 Mar-Apr;31(3):129-34

Department of Internal Medicine, Philipps University, Baldingerstrasse, 35043 Marburg/Lahn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcu.10145DOI Listing
June 2003

The small spleen: sonographic patterns of functional hyposplenia or asplenia.

J Clin Ultrasound 2003 Mar-Apr;31(3):152-5

Department of Internal Medicine, Philipps University, Baldingerstrasse, 35043 Marburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcu.10148DOI Listing
June 2003

Bronchioloalveolar carcinoma: sonographic pattern of 'pneumonia'.

Eur J Ultrasound 2002 Oct;15(3):109-17

Zentrum für Innere Medizin, Klinik für Hämatologie/Onkologie, Philipps-Universität Marburg, Baldingerstrasse, 35043, Marburg, Germany.

View Article

Download full-text PDF

Source
October 2002